FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 1 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | July 13, 2026 |
Enforcement history
On 2026-07-13, Argus HQ recorded an FDA Warning Letter for Almon Healthcare Private Limited, rated "high" severity in Argus HQ's classification: Almon Healthcare Private Limited — CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (2026-07-13). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Almon Healthcare Private Limited has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- What is the most recent FDA action against Almon Healthcare Private Limited?
- The most recent FDA event Argus HQ has on file for Almon Healthcare Private Limited is dated 2026-07-13, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
- Does Argus HQ track new FDA actions for Almon Healthcare Private Limited automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Almon Healthcare Private Limited is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for Almon Healthcare Private Limited?
- 1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for Almon Healthcare Private Limited?
- July 13, 2026. Argus HQ ingests new FDA enforcement records daily.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- Almon Healthcare Private Limited vs Philips North America
- Almon Healthcare Private Limited vs Boston Scientific Corporation
- Almon Healthcare Private Limited vs Medline Industries, LP
- Almon Healthcare Private Limited vs Baxter Healthcare Corporation
- Almon Healthcare Private Limited vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Jul 13, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Regulatory Record: Almon Healthcare Private Limited. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/almon-healthcare-private-limited
"Regulatory Record: Almon Healthcare Private Limited." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/almon-healthcare-private-limited.
Argus HQ Research. "Regulatory Record: Almon Healthcare Private Limited." Digital Empire Holdings LLC. Accessed July 22, 2026. https://argushq.ai/company/almon-healthcare-private-limited.
@misc{argushq_argushq_ai_company_almon_healthcare_private_limited_2026,
title = {Regulatory Record: Almon Healthcare Private Limited},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/almon-healthcare-private-limited},
note = {Accessed: July 22, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗